The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

21 of 34 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Indenes; Antineoplastic Agents; Treatment Outcome; Administration, Oral; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
39167807
Added to directory
Source checked

Report a correction or request removal